Study of the additional effect of Kampo medicine on common cold symptoms in COVID-19 patients : Study of the additional effect of Kampo medicine on conventional treatment for common cold symptoms in mild to moderate stage COVID-19 patients, A Multicenter Randomized Clinical Trial - IMJEDI study-R1

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 06. Juli Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: coronavirus disease 2019 (COVID-19) infectious disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19);coronavirus disease 2019
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 25-08-2020, Last updated: 2022-11-24

ICTRP ID:

JPRN-jRCTs021200020

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO00462534X